340B Drug Pricing Program: The Expansion and Its Effect on Cancer Care.
antineoplastic agents
health policy
oncology nursing
outpatient clinics
Journal
Clinical journal of oncology nursing
ISSN: 1538-067X
Titre abrégé: Clin J Oncol Nurs
Pays: United States
ID NLM: 9705336
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
entrez:
19
3
2019
pubmed:
19
3
2019
medline:
6
5
2020
Statut:
ppublish
Résumé
The 340B Drug Pricing Program is a complex federal program that is intended to provide financial relief to hospitals that provide care to greater volumes of low-income, uninsured, and underinsured patients. The body of literature is growing on how cancer care has transformed since freestanding cancer hospitals became eligible for the 340B program. Currently, community oncology practices are not eligible for the 340B program.
Identifiants
pubmed: 30880808
doi: 10.1188/19.CJON.217-219
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Langues
eng